LaFI - Laboratório de Farmacologia e Imunidade, Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Alagoas, Maceió, AL, Brazil.
J Ethnopharmacol. 2010 Mar 24;128(2):377-83. doi: 10.1016/j.jep.2010.01.041. Epub 2010 Jan 25.
In this study, we attempted to identify the possible antinociceptive and anti-inflammatory actions of the aqueous phase, the ethyl acetate phase and one unknown flavonoid obtained from aerial parts of Piptadenia stipulacea, known in Brazil as "jurema-branca", "carcará" and "rasga-beiço".
Aerial parts of Piptadenia stipulacea were used and after fractionation, the flavonoid FGAL was obtained. Experiments were conducted on Swiss mice using the acetic acid-induced writhing test, the hot plate test, the formalin-induced pain test and zymosan A-induced peritonitis test.
The aqueous and ethyl acetate phases (p.o., 100mg/kg); and the flavonoid FGAL (p.o. and i.p. at 100 micromol/kg), reduced the nociception produced by acetic acid, by 49.92%, 54.62%, 38.97% and 64.79%, respectively. In vivo inhibition of nociception by the ethyl acetate phase (100mg/kg, p.o.) in the hot plate test was favorable, indicating that this fraction exhibited central activity. The ethyl acetate phase (100mg/kg, p.o.) reduced the formalin effects in both phases by 28.51% and 55.72%, respectively. Treatment with the aqueous phase (100mg/kg, p.o.) and FGAL (100 micromol/kg, i.p.) only protected the second phase by 69.76% and 68.78%, respectively. In addition, it was observed in the zymosan A-induced peritonitis test that the aqueous phase, the ethyl acetate phase and the FGAL exhibited anti-inflammatory activity, reducing significantly the number of recruit cells by 35.84%, 37.70% and FGAL (1), respectively.
These data demonstrate that the FGAL elicits pronounced antinociceptive activity against several pain models. The actions of this flavonoid probably are due to antioxidative properties. However, pharmacological and chemical studies are continuing in order to characterize the mechanism(s) responsible for this antinociceptive action and also to identify other active substances present in Piptadenia stipulacea.
在这项研究中,我们试图确定从巴西的“jurema-branca”、“carcará”和“rasga-beiço”中提取的 Pipatadenia stipulacea 地上部分的水相、乙酸乙酯相和一种未知的黄酮类化合物的可能的镇痛和抗炎作用。
使用 Pipatadenia stipulacea 的地上部分,经分馏后得到黄酮类化合物 FGAL。在瑞士小鼠中进行实验,使用醋酸诱导的扭体试验、热板试验、福尔马林诱导的疼痛试验和酵母聚糖 A 诱导的腹膜炎试验。
水相和乙酸乙酯相(口服,100mg/kg);以及黄酮类化合物 FGAL(口服和腹腔注射 100µmol/kg),分别减少了醋酸引起的疼痛反应的 49.92%、54.62%、38.97%和 64.79%。在热板试验中,乙酸乙酯相(口服,100mg/kg)对体内疼痛的抑制作用是有利的,表明该部分表现出中枢活性。乙酸乙酯相(口服,100mg/kg)分别减少了福尔马林在两个阶段的影响 28.51%和 55.72%。水相(口服,100mg/kg)和 FGAL(腹腔注射 100µmol/kg)治疗仅分别保护了第二阶段的 69.76%和 68.78%。此外,在酵母聚糖 A 诱导的腹膜炎试验中观察到,水相、乙酸乙酯相和 FGAL 表现出抗炎活性,分别显著减少了 35.84%、37.70%和 FGAL(1)的募集细胞数量。
这些数据表明,FGAL 对几种疼痛模型具有明显的镇痛作用。该黄酮类化合物的作用可能归因于抗氧化性质。然而,正在进行药理学和化学研究,以确定负责这种镇痛作用的机制,并鉴定 Piptadenia stipulacea 中存在的其他活性物质。